You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

195 Results
Guidelines and Advice
Status: Archived
ID: 1-1
Version: 3
Sep 2011
Cancer facts
Feb 2018
Guidelines and Advice
Status: Education and Information
ID: 22-1
May 2017
Guidelines and Advice
Status: Archived
ID: 1-13
Sep 2008
Guidelines and Advice
Status: Current
Dec 2012
Cancer facts
Mar 2018
Guidelines and Advice
Status: Current
ID: GL-1-A-2016-2
Oct 2017
Guidelines and Advice
Status: Current
ID: GL 1-23-A
Jul 2021
Guidelines and Advice
Status: Archived
ID: DIBrCa
Apr 2012
Guidelines and Advice
Status: Archived
ID: 13-1
Aug 2003
Regimen
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Neoadjuvant, Adjuvant
Drugs Used:
DOXOrubicin,
cyclophosphamide
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jun 2020
Regimen
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant
Funding:
ODB - General Benefit
    exemestane
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
exemestane
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2025

Pages